Oxford Drug Design

Dr Michael Charlton presents at CCG’s European User Group Meeting

Dr Michael Charlton recently presented our work in designing novel aminoacyl tRNA synthetase inhibitors at the Chemical Computing Group’s European User Group meeting in Oxford.

Michael showed how we use CCG’s MOE modelling software in combination with our own ligand-based virtual screening methods to design novel inhibitors of leucyl tRNA synthetase.


Oxford Drug Design Ltd
Oxford Centre for Innovation
Blue Boar Court
9 Alfred Street
Oxford OX1 4EH, UK

contactus@oxforddrugdesign.com

Quick Links

© Oxford Drug Design. All Rights Reserved 2023. OXFORD DRUG DESIGN and the ‘O’ Design are trade marks of Oxford Drug Design Limited.